Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism AHR agonists(Aryl hydrocarbon receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H14N6O2 |
InChIKeyYPJBFJXVAVYURV-UHFFFAOYSA-N |
CAS Registry3083227-29-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dermatitis, Atopic | Preclinical | United States | 16 May 2025 | |
| Psoriasis | Preclinical | United States | 16 May 2025 |





